EW FY 2021 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.2B+19.3% YoY

Gross Profit

$4.0B76.6% margin

Operating Income

$1.6B30.8% margin

Net Income

$1.5B28.7% margin

EPS (Diluted)

$2.38

Cash Flow

Operating Cash Flow

$1.7B

Free Cash Flow

$1.4B

Stock-Based Comp.

$109M

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$2.7B

Stockholders' Equity

$5.8B

Cash & Equivalents

$863M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.2B	$4.4B	+19.3%
Gross Profit	$4.0B	$3.3B	+21.9%
Operating Income	$1.6B	$1.3B	+24.3%
Net Income	$1.5B	$823M	+82.5%